Global Antibiotic Research & Development Partnership

The Global Antibiotic Research & Development Partnership (GARDP) is a Swiss non-governmental organization based in Geneva, Switzerland. GARDP “engages in public and private sector partnerships to research and develop new drugs that fit public health needs.”1)

History

GARDP was founded in 2016 by the World Health Organization (WHO) and the Drugs for Neglected Diseases Initiative (DNDi).2)

Organization

Affiliations

Name Position Notes
Marco Cavaleri Expert3) Head of Biological Health Threats and Vaccines Strategy at the European Medicines Agency (EMA)

Partners

GARDP's programming and funding partners include:4)

REVIVE

GARDP launched REVIVE in January 2018 to promote the continued acceleration of antimicrobial resistance research and development.5) REVIVE co-organizes the Antimicrobial Chemotherapy Conference with the British Society for Antimicrobial Chemotherapy (BSAC). Additional partners include:

3)
Kouassi, V. Marco Cavaleri. REVIVE. Retrieved March 8, 2023, from https://web.archive.org/web/20230308225834/https://revive.gardp.org/marco-cavaleri/
4)
Balasegaram, M., & Laxminarayan, R. (2022, October 14). GARDP Interactive Activity Report 2021. GARDP. https://web.archive.org/web/20230308232439/https://gardp.org/publications/gardp-interactive-activity-report-2021/
Back to top